Invuity’s patented Intelligent Photonics® devices provide direct visualization of the surgical cavity enabling enhanced precision, efficiency and safety. Our technology is integrated into sophisticated retractor systems, handheld devices and intracavity drop-in illuminators; each utilizing our proprietary waveguide technology that directs and shapes light into broad, uniform illumination to provide enhanced direct visualization inside dark surgical cavities. In addition, it converts traditional thermally hot, concentrated light output to thermally cool volumetric illumination throughout the entire surgical cavity.
Transforming Minimal access Surgeries Through Advanced Visualization
Invuity is committed to leveraging advanced photonics technology to transform and create a new standard of care for minimal access surgery.
SAN FRANCISCO, July 12, 2017 (GLOBE NEWSWIRE) -- Invuity’s (Nasdaq:IVTY) PhotonBlade, precision illuminator with next-generation enhanced energy, is one of the medical innovations that was showcased in front of thousands of healthcare providers at Premier Inc.’s 2017 Breakthroughs Conference and Exhibition on June 27. PhotonBlade was debuted during the conference’s annual Innovation Celebration. The event recognizes advances in healthcare while highlighting industry suppliers committed to innovation and improving patient outcomes. “Invuity shares Premier’s commitment to providing valuable products to our alliance members that are safe, high-quality and cost-effective,” said Durral R. G...Read More
SAN FRANCISCO, July 11, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2017 second quarter financial results after the market closes on Tuesday, July 25, 2017. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Tuesday, July 25 2017, to discuss the financial results and other business developments. Interested parties may access the live call via telephone by dialing 1-877-556-8638 (U.S.) or 1-615-247-0174 (International), Conference ID: 51160313. To listen to the li...Read More
SAN FRANCISCO, June 13, 2017 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a medical technology company focused on minimal access surgery, today provided an update on plans for PhotonBlade commercialization. As previously announced, the Company began a limited market release of PhotonBlade in March, 2017. During this phase, the Company gathered feedback on product performance which has informed upcoming product enhancements for PhotonBlade. In addition, a small number of customer observations were recently received, which related to possible unintended energy discharge with the potential to cause tissue damage to patients. To mitigate the potential for patient injury, the Company has...Read More
“Invuity’s technology enables me to perform advanced breast procedures with remarkable visualization. This is truly an enabling technology that will be greatly appreciated by dedicated breast surgeons and plastic surgeons.”
Mission Viejo, CA
“The Invuity Eika illuminated minimally invasive thyroid and parathyroid self-retracting technology has revolutionized our field of endocrine surgery. It allows for smaller incisions while improving surgical efficiency and safety. It provides superior visualization of vital structures, and has reduced operating times, improved patient outcomes, and decreased overall costs of the procedure. I would not do a case without this technology.”
Chief of Surgery, Mission Regional and Trauma Med Ctr.
Director, St. Joseph and Hoag Head & Neck Oncology & Endocrine Center
“The Invuity illuminated retractors are a must for anyone looking to do nipple sparing mastectomies. I feel we can save significant amounts of surgical time since we can see better without the worry of burn injury or fire hazard often found with fiber optic light.”
Past President, American Society of Breast Surgeons
Chief of Breast Surgery
Professor of Surgery, Weill Cornell Medical College
Edwin C. Weiskopf Professor of Surgical Oncology New York, NY